Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.
about
Retargeting Strategies for Oncolytic Herpes Simplex VirusesGene therapy for malignant glioma.The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Designing Herpes Viruses as Oncolytics.A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4The art of gene therapy for glioma: a review of the challenging road to the bedsideAkt1, EMSY, BRCA2 and type I IFN signaling: a novel arm of the IFN response.The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.Glioma virus therapies between bench and bedside.Recent advances in oncolytic virus design.Newcastle disease virus: a promising agent for tumour immunotherapy.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer.Advances in the mechanisms of action of cancer-targeting oncolytic viruses.
P2860
Q26765439-D6712A56-F031-4268-BDE0-9E4100550F5AQ35673628-EF1D9213-6E54-4DD7-B0E6-8E70F9CBC3F6Q35844958-3DDA9925-8DF6-4E40-AB1A-155EDED2C373Q36061803-807C626B-30A4-4E29-AC3B-9B72B0F5F8EFQ36109704-81F9C5AA-7590-47A6-AB8F-D86BCCFC0608Q36142487-8EA95BEB-E1F1-47DB-BBC1-7537C30CD494Q36299683-CA584E5E-F439-4E84-84E8-69F0592F6A19Q36527593-6B3BA168-519C-4CA8-B311-32A47C05DC2BQ36777893-9CCED013-C238-4C30-99E2-E6BB38ADE60DQ37459624-FC501DEF-82F6-496D-B875-15B3BD9E4FDDQ37580510-159024F7-7518-4BA9-A8A1-5E9930CA4818Q37865172-4AD635C2-C204-42AA-AE13-FF41127AEC32Q37972664-DC3B5A9C-6F10-4969-9067-38A78684F5D1Q38025696-6F5B7D7F-A16B-448A-B6AC-23746CC1C1F0Q47557634-AFB8A720-659D-42B2-9AE3-4E61BF2D81B4Q52655195-6253D681-D831-47C8-8649-9D791E3A44F2
P2860
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of an oncolytic he ...... cific HIF-responsive promoter.
@en
Development of an oncolytic he ...... cific HIF-responsive promoter.
@nl
type
label
Development of an oncolytic he ...... cific HIF-responsive promoter.
@en
Development of an oncolytic he ...... cific HIF-responsive promoter.
@nl
prefLabel
Development of an oncolytic he ...... cific HIF-responsive promoter.
@en
Development of an oncolytic he ...... cific HIF-responsive promoter.
@nl
P2093
P2860
P356
P1433
P1476
Development of an oncolytic he ...... cific HIF-responsive promoter.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2010.62
P577
2010-10-08T00:00:00Z